Stock listing

Healtheuniverse Inc

Selected listing: HLUN · OTC · USD · US

Healtheuniverse Inc (OTC:HLUN), Commercial Services. Latest release Jun 21, 2025: New data from phase III trial confirms efficacy of Vyepti® (eptinezumab)…

HLUN:OTCUSDUSUpdated October 2, 2026
Healtheuniverse Inc logo
Ticker
OTC:HLUN
Asset type
Stock
Sector
Commercial Services
Industry
Miscellaneous Commercial Services
Exchange
OTC
Currency
USD

About Healtheuniverse Inc

The company focuses on health-related innovations and solutions. As a publicly traded entity, it is subject to regulatory oversight and market fluctuations.

Latest news from Healtheuniverse Inc

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

June 21, 2025

SEC Order Of Suspension Of Trading

March 7, 2007

All Healtheuniverse Inc news →

Research Healtheuniverse Inc

Healtheuniverse Inc company profile

View the public company page for Healtheuniverse Inc on 6ix.

Healtheuniverse Inc news

Read company news and market updates connected to Healtheuniverse Inc.

Healtheuniverse Inc investor events

Find investor webinars, events, and replay context for Healtheuniverse Inc.